LAS VEGAS, NV—Vascular closure complications occur in about one-quarter of patients undergoing transfemoral TAVR, according to post hoc analysis of the BRAVO 3 trial, but not all closure devices ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LAS VEGAS — In a comparison of two vascular closure ...

For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...

LAS VEGAS -- Bleeding complication risk after transcatheter aortic valve replacement (TAVR) isn't the same between two of the most commonly used femoral vascular closure devices, one study showed, ...

Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...

Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.

The plug-based Manta (Teleflex) device was associated with significantly more vascular complications than the suture-based ProGlide (Abbott Vascular) device following transfemoral transcatheter aortic ...

HOLLYWOOD, FL—Several large-bore closure devices seem poised to soon enter the US interventionalist’s toolbox, with “explosive growth” expected in their use given the rise in transcatheter aortic ...

LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...